Mpox and HIV: a Narrative Review

[1]  N. K. Shah,et al.  An Mpox-Related Death in the United States. , 2023, The New England journal of medicine.

[2]  E. Mosites,et al.  Possible Undetected Mpox Infection Among Persons Accessing Homeless Services and Staying in Encampments — San Francisco, California, October–November 2022 , 2023, MMWR. Morbidity and mortality weekly report.

[3]  Caroline A. Schrodt,et al.  Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023 , 2023, MMWR. Morbidity and mortality weekly report.

[4]  K. McFaul,et al.  Necrotizing Blepharoconjunctivitis and Keratitis in Human Monkeypox. , 2023, JAMA ophthalmology.

[5]  M. Peppelenbosch,et al.  Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. , 2023, The Journal of infectious diseases.

[6]  J. Collins,et al.  Monkeypox presenting as supraglottitis in an immunocompromised patient , 2023, BMJ Case Reports.

[7]  B. Clotet,et al.  Mpox in people with advanced HIV infection: a global case series , 2023, The Lancet.

[8]  S. Valdés-Ferrer,et al.  Fulminant mpox as an AIDS-defining condition: useful or stigmatising? , 2023, The Lancet.

[9]  R. Arbel,et al.  Real-world effectiveness of a single dose of mpox vaccine in males , 2023, Nature Medicine.

[10]  Caitlin A. Contag,et al.  Case Report: Monkeypox - Not Just a Rash. , 2023, The American journal of tropical medicine and hygiene.

[11]  M. Barer,et al.  Transmission of monkeypox/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak , 2023, Journal of medical virology.

[12]  P. Muir,et al.  Case of apparent mpox reinfection , 2023, Sexually Transmitted Infections.

[13]  S. Quoilin,et al.  Diagnostic approach to monkeypox outbreak, a case-control study , 2023, International journal of STD & AIDS.

[14]  G. Whitlock,et al.  Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation , 2023, Sexually Transmitted Infections.

[15]  J. Mingorance,et al.  Sexually transmitted infections and clinical features in monkeypox (mpox) patients in Madrid, Spain , 2023, Travel medicine and infectious disease.

[16]  S. Vermund,et al.  Clinical Characteristics of Human Mpox (Monkeypox) in 2022: A Systematic Review and Meta-Analysis , 2023, Pathogens.

[17]  A. Rodríguez-Morales,et al.  Detection of Monkeypox Virus according to The Collection Site of Samples from Confirmed Cases: A Systematic Review , 2022, Tropical medicine and infectious disease.

[18]  J. Klausner,et al.  A Position Statement on Mpox as a Sexually Transmitted Disease , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Matthew M. Cole,et al.  Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[20]  J. Chow,et al.  Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak , 2022, American journal of ophthalmology case reports.

[21]  H. Günthard,et al.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. , 2022, JAMA.

[22]  S. Marmon,et al.  Demographics and disease associations of patients with mpox and recipients of mpox vaccine from safety net hospitals in New York City: A cross-sectional study , 2022, Journal of the American Academy of Dermatology.

[23]  Mayur R Gamit,et al.  Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. , 2022, The Lancet. Infectious diseases.

[24]  J. Gonzales-Zamora,et al.  Clinical presentation of Monkeypox among people living with HIV in South Florida: a case series. , 2022, Le infezioni in medicina.

[25]  A. Henao-Martínez,et al.  Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort , 2022, AIDS.

[26]  W. Hanage,et al.  Monkeypox Virus Infections in Humans , 2022, Clinical microbiology reviews.

[27]  J. Zucker,et al.  New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus , 2022, Antimicrobial agents and chemotherapy.

[28]  Jonathan Bryant-Genevier,et al.  Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response — United States, May 17–October 6, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[29]  H. Perazzo,et al.  Monkeypox outbreak as an opportunity to identify new cases of HCV infection in limited resource settings , 2022, Journal of viral hepatitis.

[30]  C. Agrati,et al.  Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study , 2022, The Lancet. Infectious diseases.

[31]  J. Gonzales-Zamora,et al.  Severe monkeypox with superimposed bacterial infection in an immunocompetent patient: A case report , 2022, IDCases.

[32]  M. Díaz-Menéndez,et al.  Human monkeypox outbreak: Epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study , 2022, Journal of the American Academy of Dermatology.

[33]  H. Lopez-Gatell,et al.  Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study , 2022, Lancet Regional Health. Americas.

[34]  A. Virgolino,et al.  Clinical and Epidemiological Features of Hospitalized and Ambulatory Patients with Human Monkeypox Infection: A Retrospective Observational Study in Portugal , 2022, Infectious disease reports.

[35]  Cameron R. Wolfe,et al.  Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[36]  D. Holland,et al.  A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events — Georgia, August 27–September 5, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[37]  L. Martínez-García,et al.  Human Monkeypox in People With HIV: Transmission, Clinical Features, and Outcome , 2022, Open forum infectious diseases.

[38]  Gail L. Thompson,et al.  Ocular Monkeypox — United States, July–September 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[39]  C. Pasquier,et al.  A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome , 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[40]  C. Mussini,et al.  Monkeypox vaccination—an opportunity for HIV prevention , 2022, The Lancet HIV.

[41]  Christopher Owens,et al.  Findings on the Monkeypox Exposure Mitigation Strategies Employed by Men Who Have Sex with Men and Transgender Women in the United States , 2022, Archives of Sexual Behavior.

[42]  K. O'Laughlin,et al.  Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[43]  P. Peters,et al.  HIV and Sexually Transmitted Infections Among Persons with Monkeypox — Eight U.S. Jurisdictions, May 17–July 22, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[44]  M. Tay,et al.  Monkeypox: disease epidemiology, host immunity and clinical interventions , 2022, Nature Reviews Immunology.

[45]  Michael J. Rausch,et al.  Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany , 2022, HIV medicine.

[46]  V. Calvez,et al.  Viral loads in clinical samples of men with monkeypox virus infection: a French case series , 2022, The Lancet. Infectious diseases.

[47]  Jennifer Abbasí.  Reports of Asymptomatic Monkeypox Suggest That, at the Very Least, Some Infections Go Unnoticed. , 2022, JAMA.

[48]  A. Lansky,et al.  Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[49]  Stuart H. Cohen,et al.  Phimosis as a Complication of Resolved Monkeypox. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  V. Corman,et al.  Monkeypox in-patients with severe anal pain , 2022, Infection.

[51]  David H. Philpott,et al.  Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022. , 2022, MMWR. Morbidity and mortality weekly report.

[52]  J. Brooks,et al.  Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[53]  E. Nicastri,et al.  Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding , 2022, The Lancet. Infectious diseases.

[54]  D. Chilton,et al.  Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series , 2022, BMJ.

[55]  L. Borio,et al.  The WHO Declaration of Monkeypox as a Global Public Health Emergency. , 2022, JAMA.

[56]  A. Antinori,et al.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.

[57]  Y. Nakazawa,et al.  Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model , 2021, mSphere.

[58]  C. Ihekweazu,et al.  Clinical course and outcome of human monkeypox in Nigeria. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  Joachim Hornung,et al.  Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox. , 2019, The New England journal of medicine.

[60]  FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox , 2019, Case Medical Research.

[61]  G. Sutter,et al.  Chapter Five Modified Vaccinia Virus Ankara History, Value in Basic Research, and Current Perspectives for Vaccine Development , 2017, Advances in Virus Research.

[62]  T. Marbury,et al.  A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects , 2016, PloS one.

[63]  Johannes B. Goll,et al.  Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects , 2015, Vaccine.

[64]  I. Frank,et al.  Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial , 2015, Open forum infectious diseases.

[65]  R. Wittek.  Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[66]  L. Naesens,et al.  Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection , 2006, Nature.

[67]  R. Jordan,et al.  An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge , 2005, Journal of Virology.

[68]  M. Jadoul,et al.  Cidofovir-induced end-stage renal failure. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  R. Davey,et al.  Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria , 1995, Antimicrobial agents and chemotherapy.

[70]  T. Schwartz.  [Eradication of smallpox]. , 1980, Harefuah.

[71]  K. Beard,et al.  Clinical Features and Management of Individuals Hospitalised with Monkeypox and Associated Complications in the UK: A Retrospective Analysis Across 16 Hospitals , 2022, SSRN Electronic Journal.